The magnetic resonance imaging 'rule of five': Predicting the occurrence of relapse

Multiple Sclerosis Journal

Volumn 19, Issue 13, 2013, Pages 1760-1764

  Morgan, Charity J ^a   Ranjan, Ashutosh ^a   Aban, Inmaculada B ^a   Cutter, Gary R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

logistic regression; magnetic resonance imaging scans; Multiple sclerosis; relapsing remitting; safety monitoring

Indexed keywords

MN 166; NEUROPROTECTIVE AGENT; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CODING; PHASE 2 CLINICAL TRIAL; PREDICTIVE VALIDITY; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; RELAPSE; RISK ASSESSMENT;

LOGISTIC REGRESSION; MAGNETIC RESONANCE IMAGING SCANS; MULTIPLE SCLEROSIS; RELAPSING-REMITTING; SAFETY MONITORING;

ADOLESCENT; ADULT; FEMALE; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; RECURRENCE; ROC CURVE; YOUNG ADULT;

EID: 84887516913     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513485147     Document Type: Article

References (11)

1. O'Connor P.. Key issues in the diagnosis and treatment of multiple sclerosis: An overview. Neurology. 2002 ; 59: S1 - S33
2. Petkau J, Reingold SC, Held U, et al. Magnetic resonance imaging as surrogate outcome for multiple sclerosis relapses. Mult Scler. 2008 ; 14: 770-778
3. Sormani MP, Li DK, Bruzzi P, et al. Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis. Neurology. 2011 ; 77: 1684-1690
4. Comi G, Jeffery D, Kappos L, et al. Placebo-controlled trial of oral laquinimod for multiple sclerosis. N Engl J Med. 2012 ; 366: 1000-1009
5. Lublin F, Cutter G, Elfont R, et al. A trial to assess the safety of combining therapy with interferon β-1a and glatiramer acetate in patients with relapsing MS. Neurology. 2001 ; 3: A148
6. Riddell CA, Zhao Y, Li DKB, et al. Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis. Neurology. 2011 ; 77: 2089-2096
7. Barkhof F, Hulst HE, Drulovic J, et al. Ibudilast in relapsing-remitting multiple sclerosis: A neuroprotectant?. Neurology. 2010 ; 74: 1033-1040
8. Akaike H.. A new look at the statistical model identification. IEEE Trans on Autom Control. 1974 ; 19: 716-723
9. Hurvich CM, Tsai CL.. Regression and time series model selection in small samples. Biometrika. 1989 ; 76: 297-307
10. Hardin JW, Hilbe JM Generalized estimating equations. 2 nd ed. Boca Raton, FL: Chapman and Hall/CRC Press, 2012. Boca Raton, FL: Chapman and Hall/CRC Press ; 2012:
11. Hosmer DW, Lemeshow S Applied logistic regression. 2 nd ed.New York: Wiley, 2000. New York: Wiley ; 2000: and Stroke Stroke